ProfileGDS4718 / 226807_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 56% 41% 84% 44% 54% 68% 73% 46% 46% 50% 56% 55% 62% 74% 67% 59% 62% 77% 72% 54% 42% 53% 58% 58% 58% 75% 52% 66% 53% 71% 67% 70% 38% 59% 72% 71% 54% 54% 42% 83% 58% 76% 74% 72% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.8865156
GSM549102patient 115, normal, homogenized [OPG study]5.0488541
GSM549104patient 119, normal, homogenized [OPG study]8.3816584
GSM549108patient 138, normal, homogenized [OPG study]5.2645644
GSM549119patient 077, normal, homogenized [OPG study]5.7727754
GSM549133patient 032, cancer, homogenized [OPG study]6.7714968
GSM549139patient 042, cancer, homogenized [OPG study]7.1312173
GSM549099patient 107, normal, homogenized [OPG study]5.3161346
GSM549109patient 139, normal, homogenized [OPG study]5.3440846
GSM549110patient 046, normal, homogenized [OPG study]5.4927750
GSM549114patient 063, normal, homogenized [OPG study]5.7913856
GSM549122patient 082, normal, homogenized [OPG study]5.8194455
GSM549134patient 033, cancer, homogenized [OPG study]6.2704462
GSM549136patient 036, cancer, homogenized [OPG study]7.335574
GSM549140patient 044, cancer, homogenized [OPG study]6.6947467
GSM549111patient 047, normal, homogenized [OPG study]6.0364759
GSM549113patient 057, normal, homogenized [OPG study]6.2452262
GSM549132patient 031, cancer, homogenized [OPG study]7.5498377
GSM549137patient 038, cancer, homogenized [OPG study]7.1092372
GSM549142patient 047, cancer, homogenized [OPG study]5.8856954
GSM549100patient 110, normal, homogenized [OPG study]5.1162342
GSM549107patient 135, normal, homogenized [OPG study]5.6822653
GSM549115patient 068, normal, homogenized [OPG study]5.9377758
GSM549116patient 072, normal, homogenized [OPG study]5.9990858
GSM549120patient 078, normal, homogenized [OPG study]6.0209158
GSM549131patient 030, cancer, homogenized [OPG study]7.4324675
GSM549118patient 074, normal, homogenized [OPG study]5.6368952
GSM549129patient 027, cancer, homogenized [OPG study]6.6255366
GSM549123patient 088, normal, homogenized [OPG study]5.6686153
GSM549124patient 006, cancer, homogenized [OPG study]6.9261871
GSM549126patient 015, cancer, homogenized [OPG study]6.6559567
GSM549128patient 025, cancer, homogenized [OPG study]6.9086970
GSM549103patient 117, normal, homogenized [OPG study]4.9806838
GSM549117patient 073, normal, homogenized [OPG study]6.013259
GSM549138patient 041, cancer, homogenized [OPG study]7.1367472
GSM549141patient 045, cancer, homogenized [OPG study]7.0100571
GSM549130patient 028, cancer, homogenized [OPG study]5.7150154
GSM549101patient 111, normal, homogenized [OPG study]5.7629954
GSM549105patient 128, normal, homogenized [OPG study]5.1253142
GSM549106patient 134, normal, homogenized [OPG study]8.3502383
GSM549112patient 048, normal, homogenized [OPG study]5.9639558
GSM549125patient 011, cancer, homogenized [OPG study]7.4177876
GSM549127patient 024, cancer, homogenized [OPG study]7.3117474
GSM549135patient 035, cancer, homogenized [OPG study]7.1680172